GF/B47/EDP11
Approved by the Board on: 12 August 2022
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation
The Board:
- Approves the funding recommended for each country disease component, and its constituentgrants, as listed in Table 1 of GF/B47/ER09 (“Table 1”);
- Acknowledges each country disease component’s constituent grants will be implemented by theproposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemedappropriate by the Secretariat in accordance with Global Fund policies;
- Affirms the funding approved under this decision (a) is subject to the availability of funding, and(b)shall be committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding availablefor each country disease component among its constituent grants, provided that the TechnicalReview Panel (the “TRP”) validates any redistribution that constitutes a material change fromthe program and funding request initially reviewed and recommended by the TRP.
Budgetary Implications
This decision does not have material budgetary implications for operating expenses.